Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

This study has been completed.

Sponsor:

ClinicalTrials.gov Identifier:

NCT00166179

First Posted: September 14, 2005

Last Update Posted: September 26, 2014

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by (Responsible Party):

Randolph E Patterson, Emory University

Purpose

The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.

Condition
Coronary Artery Disease


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

Resource links provided by NLM:

MedlinePlus related topics: Diagnostic Imaging MRI Scans

U.S. FDA Resources

Further study details as provided by Randolph E Patterson, Emory University:

Primary Outcome Measures:

Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI [ Time Frame: time of initial scans ]

Secondary Outcome Measures:

Compare size of regions of viable and non viable myocardium as % left ventricle by MRI vs. PET [ Time Frame: at time of initial scans ]


Enrollment:	57
Study Start Date:	November 2003
Study Completion Date:	October 2006
Primary Completion Date:	October 2006 (Final data collection date for primary outcome measure)

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	18 Years to 95 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Age > 25 yrs, mean + SD = 60.3 + 10.2, 83% male, are patients referred by cardiologist or cardiac surgeon for assessment of myocardial viability by PET FDG.

Criteria

Inclusion Criteria:

PET-FDG ordered to assess myocardial viability

Exclusion Criteria:

Contraindicated for MRI
Pregnant
Age <25 yrs

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00166179

Locations


United States, Georgia
Crawford Long Hospital
Atlanta, Georgia, United States, 30308

Sponsors and Collaborators

Emory University

Investigators


Principal Investigator:	Randolph Patterson, MD	Staff

More Information


Responsible Party:	Randolph E Patterson, Professor, Emory University
ClinicalTrials.gov Identifier:	NCT00166179 History of Changes
Other Study ID Numbers:	IRB00000292 6-56550 ( Other Identifier: Other )
First Submitted:	September 13, 2005
First Posted:	September 14, 2005
Last Update Posted:	September 26, 2014
Last Verified:	September 2014

Keywords provided by Randolph E Patterson, Emory University:


CAD

Additional relevant MeSH terms:


Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases	Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases

To Top